Neratinib stimulates senescence of mammary cancer cells by reducing the levels of SIRT1
Figure 8.The effects of Neratinib in the expression of SIRT1. (A) mRNA of SIRT1; (B) Protein levels of SIRT1 as measured by Western blot (^, ^^, ^^^, P<0.05, 0.01, 0.005 vs. vehicle group).